PRL and hyperprolactinemia: Furthermore, the observed decrease in prolactin following O3FA treatment of BPF-induced hyperprolactinemia agrees with Emsley et al.56, that observed that eicosapentaenoic acid (EPA) decreased the level of circulating prolactin in psychiatric patients.